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Abstract 
Background and purpose: The appropriate fixation method for hemiarthroplasty of the 
hip as it relates to implant survivorship and patient mortality is a matter of ongoing 
debate.  
Methods: We analyzed approximately 25,000 hemiarthroplasty cases from the AOA 
National Joint Replacement Registry. Deaths at 1 day, 1 week, 1 month, and 1 year 
were compared for all patients and among subgroups based on implant type.  
Results: Patients treated with cemented monoblock hemiarthroplasty had a 1.7 times 
higher day 1 mortality compared to uncemented monoblock components (p<0.001). 
This finding was reversed by 1 week, 1 month and 1 year post surgery (p<0.001). 
Modular hemiarthroplasties did not reveal a difference in mortality between fixation 
methods at any time-point.  
Interpretation: This study demonstrates lower (or similar) overall mortality with 
cemented hemiarthroplasty of the hip. 
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Introduction 
The frequency of hip fractures is increasing with our ageing population with an annual 
incidence of between 1.4-5 per 103 per year (Lonnroos et al. 2006, Icks et al. 
2008,varez-Nebreda et al. 2008). Health model projections have estimated that 6.3 
million hip fractures will occur annually worldwide within the next 40 years (Cooper et al. 
1992), imposing a significant economic health burden. There is a large reported peri-
operative mortality rate in this population, ranging from 2.4 to 8.2% at 1 month (Parvizi 
et al. 2001, Radcliff et al. 2008), and over 25% at 1 year (Elliott et al. 2003, Jiang et al. 
2005). Furthermore, it was recently reported that the current mortality rate is higher now 
than 25 years ago (Vestergaard et al. 2007a). It is today largely accepted that displaced 
intracapsular fractures are best treated with arthroplasty rather than internal fixation 
(Keating et al. 2006, Leighton et al. 2007). However, in the at-risk population, multiple 
comorbidities are common, and the best component fixation is in question. 
 
Bone cement implantation syndrome is a well described complication of cemented hip 
arthroplasty. It is characterized by a systemic drop in systolic blood pressure, 
hypoxemia, pulmonary hypertension, cardiac dysrhythmias, and occasionally cardiac 
arrest and death (Rinecker 1980, Orsini et al. 1987, Parvizi et al. 1999). The prevailing 
theory to explain the pathophysiology of this phenomenon is embolism of fat, marrow 
contents, bone, and to some degree methylmethacrylate to the lung (Rinecker 1980, 
Elmaraghy et al. 1998, Parvizi et al. 1999, Koessler et al. 2001). An increased 
pulmonary insult with fat microemboli has been demonstrated (by mostly randomized 
controlled trials) during insertion of a cemented femoral stem compared to uncemented 
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implants (Orsini et al. 1987, Ries et al. 1993, Christie et al. 1994, Pitto et al. 1999), 
presumably due to increased intramedullary femoral canal pressures in the cemented 
group (Kallos et al. 1974, Orsini et al. 1987). These pressures can be reduced by the 
use of distal venting holes in the femur during stem insertion (Engesæter et al. 1984). It 
has previously been shown via single institutional review that patients undergoing 
cemented hip arthroplasty have a higher intraoperative mortality rate relative to 
uncemented arthroplasty, presumably due to a reduced incidence of fat embolism in the 
latter group (Parvizi et al. 1999). The increased mortality risk was also present at 30 
days in the treatment of acute fractures with cemented arthroplasty, also from a single 
institutional review (Parvizi et al. 2004). Although cement-related mortality is rare 
(Dearborn and Harris 1998, Parvizi et al. 1999, Parvizi et al. 2001, Parvizi et al. 2004, 
Weinrauch et al. 2006), it is a devastating complication, often reported via observational 
studies or literature reviews. Proponents of uncemented hip arthroplasty often cite this 
concern to support their reluctance to use cemented hip arthroplasty in both elective 
procedures and fracture management. However, there have been many different types 
of studies that have been unable to identify any increased mortality risk with the use of 
cement (Lausten and Vedel 1982 (observational), Emery et al. 1991 (RCT), Lo et al. 
1994 (observational), Khan et al. 2002a,b (literature review), Parker and Gurusamy 
2004 (literature review)) and others have shown a decrease in mortality at 30 days 
when cement is used (Foster et al. 2005).  
 
Results of cemented hip hemiarthroplasty offer improved rate of return to baseline 
function, reduced post-operative pain, and superior long-term survivorship relative to 
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uncemented arthroplasty (Khan et al. 2002a,b, Parker and Gurusamy 2004). We 
reasoned that failure to return to baseline function after hemiarthroplasty may be 
another risk factor for peri-operative mortality (Hannan et al. 2001, Braithwaite et al. 
2003). Lower revision rates for cemented prostheses and increased mortality at revision 
surgery also further contribute to reducing the overall mortality risk. We evaluated the 
relationship between the method of fixation of hip arthroplasty and peri-operative 
mortality using a large national joint replacement registry. 
 
Patients and methods 
Data pertaining to patient age, implant type, fixation method, and patient location were 
obtained from the Australian Orthopaedic Association (AOA) National Joint 
Replacement Registry (NJRR). Mortality information was obtained by patient matching 
with the National Death Index (NDI) from the Australian Institute of Health and Welfare. 
The outcome of interest was mortality at 1 day, 1 week , 1 month, and 1 year post 
surgery. Data were then stratified by implant type to examine the effect of cement 
fixation within monoblock and modular implant procedures. 
 
The AOA NJRR identified patient selection differences for implant type based on 
demographic data. As patient comorbidities are not captured in the AOA NJRR, these 
demographics were used as a surrogate measure for different patient populations in an 
effort to adjust for bias in the comparison of fixation method. We hypothesized that 
monoblock components were typically reserved for more elderly, lower demand patients 
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with more comorbidities, and modular prosthesis implants were used in healthier 
patients with expected longer survival.  
 
Data in the AOA NJRR are collected at the time of surgery using a standard paper 
based form, with methods described in more detail elsewhere (Conroy et al. 2008, AOA 
2009,). Each hospital subsequently forwards these forms to the Registry for data entry. 
Forms with incomplete or inconsistent data are followed up by the Registry with the 
hospital concerned. Cases where forms have not been completed are identified by 
verification of Registry data using government hospitalization separation data.  
 
Statistics 
Mortality rates were compared between cemented and uncemented prostheses using a 
time dependent cox-proportional hazard model. For each model the assumption of 
proportional hazards was checked analytically by inspecting the log(-log(survival)) 
versus log of survival time graph. Time points were selected a priori based on clinical 
importance and hazard ratios were then calculated for each selected time period. All 
analyses were adjusted for age and sex as measured at the primary procedure date. All 
analyses were performed in SAS Version 9.1 (SAS Institute Inc., Cary, NC).  
 
Ethics 
Local ethical approval was not required from our institution as this study was purely data 
driven and used de-identified national data. A formal request was made to the 
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Australian Orthopaedic Association (AOA) National Joint Replacement Registry (NJRR) 
for access to the national de-identified data.  
 
Results 
Patient demographics: 
There were 12,804 patients treated with uncemented hemiarthroplasty, and 12,935 
treated with cemented hemiarthroplasty. No statistically significant differences in 
demographic characteristics between the methods of fixation were detected among the 
different groups (Table 1). 
 
Peri-operative mortality: 
Kaplan Meier survival estimates by days post-operative are shown in Figure 1 and 
hazard ratios are detailed in Table 2. There was an increased risk of peri-operative 
mortality in patients treated with uncemented hemiarthroplasty at 1 week (p = 0.02), 1 
month (p = 0.03), and 1 year (p < 0.001) post-operatively. Conversely, there was a 
greater risk of peri-operative mortality in the first post-operative day in patients treated 
with cemented components (p < 0.001), suggesting that at-risk patients are more likely 
to succumb early if cement is used. However, most patients receiving cemented 
components were treated with modular components (9,301/12,935 – 72%), whereas 
most patients receiving uncemented components received a monoblock prosthesis 
(10,362/12,804 – 81%). We therefore were interested in further characterizing the role 
of fixation method in different patient groups to identify the true effect of cement on 
mortality. 
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Cemented vs. uncemented monoblock components: 
There were 10,362 patients treated with uncemented monoblock implants, and 3,634 
patients received cemented monoblock implants. The mortality rate was higher at day 1 
when cemented monoblock implants were used (p < 0.001). This has been further 
detailed per day for the first post-operative week in Table 3. However, this difference 
was no longer statistically significant at 1 week or 1 month between groups. By 1 year, 
the death rate had reversed with a favorable survival among patients treated with 
cemented implants (p < 0.001) (Figure 2, Table 4).  
 
As comorbidities increase with age, we hypothesized that if cement was a risk factor for 
perioperative mortality, the relationship would be more evident in the elderly patients 
treated with cemented hemiarthroplasty. To evaluate this relationship, we further 
analyzed this cohort of patients stratified by age treated with cemented vs. uncemented 
hemiarthroplasty. Although numbers were relatively small (see Table 1), this analysis 
showed that elderly patients (>70) have a more favorable survivorship at 1 year when 
cemented monoblocks are compared to uncemented monoblocks (Fig. 2a; p = 0.005 & 
p < 0.001). In the older age group (>80), there was a higher 1 day mortality rate when 
using cement (p<0.001), but this difference disappeared by 1 week (p=0.5) and 1 month 
(p=0.9) and reversed by 1 year (p<0.001) where cemented implants had a more 
favorable mortality rate. 
 
Cemented vs. uncemented modular components: 
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There were 2,442 patients treated with uncemented modular components, while 9,301 
received cemented implants. There was no statistically significant difference in mortality 
at any time between the methods of fixation of modular implants (Figure 3, Table 5). 
 
Discussion 
We found a decreased mortality at 1 year following a cemented procedure compared to 
uncemented procedures. At the outset of this study, it was our hypothesis that there 
would be similar mortality rates for cemented and uncemented hemiarthroplasty using a 
large, nationwide joint registry database. The fact that the data reveal a lower overall 
mortality rate at later times with cemented monoblock procedures was surprising. 
Together with the fact that implant survival from the AOA NJRR is increased for 
cemented as compared to uncemented implants into the mid-term (AOA 2009), as well 
as previous work demonstrating improved functional outcome and pain scores with 
cemented implants (Khan et al. 2002a,b, Parker and Gurusamy 2004), it is becoming 
increasingly difficult to justify the continued preference of some surgeons for 
uncemented implants. 
 
The strength of this study lies in the large numbers available for analysis. Due to high 
data completion rates and stringent data validation protocols by the AOA NJRR, the 
data are robust and easily lend itself to this type of analysis. 
 
There are many possible explanations for our findings. Firstly, a weakness of this study 
is that selection of implant fixation was not randomized. In that regard, other patient 
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factors may have influenced surgeon decision to avoid cement, which may not have 
been adequately adjusted for in our analysis. For example, it has been shown that pre-
existing cardiac disease is an independent risk factor for cement-related mortality 
(Parvizi et al. 2004). Other risk factors for increased peri-operative mortality with hip 
fracture include age, sex, and comorbidities (Hannan et al. 2001, Jiang et al. 2005, 
Vestergaard et al. 2007b, varez-Nebreda et al. 2008). The Australian Orthopaedic 
Association National Joint Replacement Registry does not collect comorbidity data, and 
in that regard we could not rule out the possibility that selection bias for fixation method 
influenced overall patient mortality. Our subcategorization of procedures into modular 
and monoblock components was an effort to control for this variable with a surrogate 
measure, as monoblock components are typically used in the frail elderly for quicker 
surgery and less functional demand on the component post-operatively. In a separate 
analysis, we found that there was a favorable survival rate at 1 year in patients 71-80 
and >80 when cemented monoblock implants were used vs. uncemented monoblock 
components. Reasons for this are unclear, but may relate to selection of fixation method 
based on patient variables not captured by the AOA NJRR. For example, it is possible 
that elderly patients receiving cemented monoblock components are generally in better 
health than those treated with uncemented monoblock hemiarthroplasty, and are felt to 
be less likely to succumb to cement-related drop in systolic blood pressure intra-
operatively. Alternately the opposite may be true as for hip prostheses generally fitter 
(younger, healthier) individuals receive cementless prostheses. There is also 
considerable state-to-state variability in preference for fixation method (AOA 2009), as 
well as individual hospital trends, which likely reflect different training and philosophies 
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across the country. Further subanalysis of the relationship of these variables makes 
broad conclusions difficult as patient numbers decrease with further sub categorization. 
 
The cause of death was also not investigated in this study, and we therefore could not 
directly link mortality to surgery-related issues. Certainly 1 day and 1 week mortality are 
likely to be associated with peri-operative factors. Consistent with our study, Foster et 
al. (2005) found a higher 30 day mortality rate in uncemented (9%) vs. cemented (1%) 
hemiarthroplasties in a retrospective review of 244 patients, despite similar ASA grades 
in either group. 
 
Parker and Gurusamy (2004) reported their meta-analysis on the outcome of cemented 
hip arthroplasties vs. uncemented components for hip fracture, and found that mobility 
and pain at 1 year post-operatively was better in the cemented group. There was no 
difference in peri-operative mortality in their analysis. This report included over 1900 
patients, although still substantially smaller than our study. The same findings were 
corroborated in a separate meta-analysis of 18 publications addressing cemented vs. 
uncemented arthroplasty for hip fractures (Khan et al. 2002b). Khan’s group further 
compared 121 uncemented Austin-Moore hemiarthroplasty patients to 123 cemented 
Thompson implants done at 2 hospitals (Khan et al. 2002a). Patients treated with 
uncemented Austin-Moore implants had more pain, worse function in terms of walking 
and dependence on walking aids, and reduced capacity to perform activities of daily 
living as compared to patients with cement fixation. There was no statistically significant 
difference in mortality or non-fatal medical complication rates related to type of fixation 
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used. There were more intra-operative fractures (3/121 uncemented vs. 0/123 
cemented), more dislocations (3/121 vs. 0/123), and a higher failure rate (numbers not 
reported) in uncemented vs. cemented patients. In a single institution audit, Singh and 
Deshmukh (2006) reported an overall increased reoperation and revision rate using 
uncemented Austin-Moore implants vs. cemented Thompsons hemiarthroplasties. 
Patients treated with cemented implants also had a higher overall satisfaction rate 
relative to the uncemented stem. In a small randomized study comparing cemented 
Thompson’s to uncemented Austin-Moore’s implants (Emery et al. 1991), pain and 
dependence on walking aids was less if the femoral component was fixed with cement. 
There was no difference in mortality or peri-operative complications in either group. In a 
retrospective review of 107 patients treated with Thompson’s hemiarthroplasty for 
displaced femoral neck fractures, Sikorski and Millar (1977) failed to demonstrate an 
increased rate of mortality, myocardial infarction, cerebrovascular incident, cardiac 
failure, or post-operative hypotension whether or not cement was used. Similar findings 
have been reported with other cemented vs. uncemented implants (Lausten and Vedel 
1982, Lo et al. 1994). 
 
Although pulmonary fat embolization is much less common with uncemented 
components, embolic events do occur (Orsini et al. 1987, Ries et al. 1993, Pitto et al. 
1999), and this likely is related to increased intramedullary pressures during 
instrumentation of the femoral canal (Kallos et al. 1974, Orsini et al. 1987). Wenda et al 
(1995) has demonstrated that reaming the intramedullary canal produces pressures 
averaging 835 mm Hg, and that only 200 mm Hg are required for fat intravasation and 
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embolization. This compares with maximum pressures of approximately 846 mmHg 
demonstrated with introduction of cement into the femoral canal in a dog model by 
Orsini et al (1987). In fact, there are a few case reports outlining peri-operative fat 
embolism syndrome and mortality due to fat embolization with uncemented hip 
arthroplasty (Arroyo et al. 1994, Gelinas et al. 2000). It is also known that intraoperative 
complications are higher with uncemented hemiarthroplasty, including iatrogenic 
femoral fracture (Foster et al. 2005, Weinrauch et al. 2006). A randomized controlled 
trial looking at prevalence of fat and bone marrow emboli to lung based on right atrium 
blood sampling showed similar prevalences in cemented and uncemented components 
(Kim et al. 2002). Further, it has been shown that proper femoral canal lavage and 
vacuum suction reduce embolic events with cement implantation (Christie et al. 1995, 
Pitto et al. 1998). Modern cement techniques may therefore account for lower incidence 
of peri-operative mortality with cement use compared with earlier studies. 
 
In conclusion, this study shows a small but statistically significantly increased risk of 
mortality at 1 day when cement is used for monoblock hemiarthroplasty procedures. By 
1 week, there is no longer a mortality advantage by avoiding cement, and by 1 year, 
mortality is less when cement is used. This may be due to a higher overall revision rate 
with uncemented monoblock components. When modular components are compared, 
there is no mortality difference at any time analyzed, although there is a higher implant 
revision rate when uncemented components are used. These data support the use of 
cemented hemiarthroplasty components in patients with hip fracture. 
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Figures & Tables: 
 
 
Figure 1: All cause mortality in cemented and uncemented hemiarthroplasty patients. 
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Figure 2: All cause mortality for cemented and uncemented monoblock 
hemiarthroplasty. 
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Figure 2a: All cause mortality in cemented and uncemented monoblock 
hemiarthroplasty patients stratified by age. 
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Figure 3: All-cause mortality between cemented and uncemented modular 
components. 
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Table 1: Patient demographics of hemiarthroplasty procedures 
Component 
type  Total  Age  
% 
Female
   <70 71-80 >80  
Monoblock Cemented 3634 169 (4.7%) 946 (26.0%) 2519 (69.3%) 74 
 Uncemented 10362 420 (4.1%) 2550 (24.6%) 7392 (71.3%) 74 
 Subtotal 13996 589 3496 9911  
Modular Cemented 9301 1518 (16.3%) 3233 (34.8%) 4550 (49.6%) 74 
 Uncemented 2442 446 (18.3%) 750 (30.7%) 1246 (51.0%) 72 
  Subtotal 11743 1964 3983 5796  
Total  25739 2553 7479 15707  
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Table 2: Hazard ratios (HR) for risk of death by fixation for all hemiarthroplasty. 
 
  HR (95% CI) 
(cementless v cemented) 
p-value Cemented no of 
deaths (n=12,935) 
Cementless no of 
deaths (n=12,804) 
1 day 0.59 (0.43-0.79) 0.0005 109 70 
1 week 1.36 (1.05-1.74) 0.02 345 384 
1 month 1.27 (1.03-1.58) 0.03 860 1170 
1 year 1.37 (1.29-1.49) <0.0001 2680 3794 
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Table 3: Hazard ratios (HR) for day of operation to day 6 for risk of death by fixation for 
monoblock hemiarthroplasty. 
 
 Cemented Cementless 
  No at 
risk at 
start of 
period 
Deaths Cumulative 
Survival  
No at risk 
at start of 
period 
Deaths Cumulative 
Survival 
HR (cementless 
compared to 
cemented 
monoblock 
hemiarthroplasty) 
0 3634 0 100.0 10362 0 100.0  
1 3582 46 99.3 (99.0, 99.6) 10299 62 99.9 (99.8, 99.9) 0.47 (0.32-0.68) 
2 3557 70 98.7 (98.3, 99.0) 10258 102 99.4 (99.2, 99.5) 0.57 (0.35-0.95) 
3 3540 85 98.1 (97.6, 98.5) 10196 161 99.0 (98.8, 99.2) 1.35 (0.76-2.37) 
4 3524 100 97.7 (97.1, 98.1) 10143 212 98.4 (98.2, 98.7) 1.17 (0.66-2.07) 
5 3508 113 97.2 (96.7, 97.7) 10092 259 98.0 (97.7, 98.2) 1.24 (0.67-2.29) 
6 3497 123 96.9 (96.3, 97.4) 10055 295 97.5 (97.2, 97.8) 1.24 (0.61-2.49) 
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Table 4: Hazard ratios (HR) for risk of death by fixation for monoblock hemiarthroplasty. 
 
  HR (95% CI) 
(cementless v cemented) 
p-value Cemented no of 
deaths (n=3634) 
Cementless no of 
deaths (n=10,362) 
1 day 0.47 (0.32-0.68) <0.001 46 62 
1 week 1.16 (0.81-1.66) 0.43 138 340 
1 month 0.95 (0.71-1.26) 0.71 359 1051 
1 year 1.23 (1.13-1.34) <0.0001 1015 3413 
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Table 5: Hazard ratios (HR) for risk of death by fixation for modular hemiarthroplasty. 
 
  HR (95% CI) 
(cementless v cemented) 
p-value Cemented no of 
deaths (n=9301) 
Cementless no of 
deaths (n=2442) 
1 day 0.48 (0.23-1.01) 0.052 63 8 
1 week 1.18 (0.70-7.97) 0.53 207 44 
1 month 0.91 (0.55-1.49) 0.7 501 119 
1 year 0.89 (0.78-1.02)  0.09 1665 381 
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